| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
10% Owner | Director, 10% Owner | Director
9 companies
Armistice Capital, LLC is a 10% Owner at HIND with holdings across 9 companies. Recent SEC Form 4 filings include 4 buys and 40 sells.
Estimated insider holdings value: $55.8M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| May 27, 2020 | VXRT Vaxart, Inc. | Director, 10% Owner | Sell | 200,000 | $2.61 | $522,000.00 | -1.2% | |
| May 22, 2020 | VXRT Vaxart, Inc. | Director, 10% Owner | Sell | 1,750,000 | $3.10 | $5,428,500.00 | -3.2% | |
| May 18, 2020 | VXRT Vaxart, Inc. | Director, 10% Owner | Sell | 1,943,308 | $2.92 | $5,673,062.36 | -2.9% | |
| May 13, 2020 | VXRT Vaxart, Inc. | Director, 10% Owner | Sell | 3,406,692 | $2.92 | $9,962,929.04 | -4.1% | |
| May 8, 2020 | VXRT Vaxart, Inc. | Director, 10% Owner | Sell | 250,000 | $2.53 | $632,000.00 | -0.3% | |
| May 5, 2020 | VXRT Vaxart, Inc. | Director, 10% Owner | Sell | 2,650,000 | $2.68 | $7,089,425.31 | -2.6% | |
| Apr 30, 2020 | VXRT Vaxart, Inc. | Director, 10% Owner | Sell | 6,600,000 | $3.05 | $20,122,351.10 | -4.8% | |
| Apr 27, 2020 | AYTU Aytu Biopharma, Inc | Director | Sale+OE | 5,108,921 | $1.82 | $9,298,236.22 | -100% | |
| Apr 3, 2020 | AVTX Avalo Therapeutics, Inc. | Director, 10% Owner | Buy | 4,280 | $2.16 | $9,244.80 | +0.5% | |
| Mar 31, 2020 | AVTX Avalo Therapeutics, Inc. | Director, 10% Owner | Buy | 111,914 | $2.37 | $265,345.68 | +4.9% |